Financing, Equity Capital Markets

Boundless Bio, Inc.

03/24
|
$100.0 Million
Boundless Bio, Inc.
Piper Sandler served as bookrunner for Boundless Bio, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma